Atlas Trials

Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Clinical trial NCT06511050 · RECRUITING

Trial details

NCT number
NCT06511050
Sponsor
Icahn School of Medicine at Mount Sinai
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Long CovidPost-treatment Lyme Disease SyndromeChronic Fatigue SyndromeMyalgic Encephalomyelitis
Start date
2024-10-09
Primary completion
2026-12-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.